Hjem
Liv Cecilie Vestrheim Thomsens bilde

Liv Cecilie Vestrheim Thomsen

Forsker
  • E-postLiv.Vestrheim@uib.no
  • Telefon+47 909 35 449
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • 2019. Metabolomics identifies placental dysfunction and confirms Flt-1 (FMS-like tyrosine kinase receptor 1) biomarker specificity. Hypertension. 1136-1143.
  • 2018. rs495139 in the TYMS-ENOSF1 region and risk of ovarian carcinoma of mucinous histology. International Journal of Molecular Sciences. 1-13.
  • 2018. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLOS ONE. 1-13.
  • 2018. Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. Clinical and Experimental Immunology. 84-94.
  • 2018. Placental inflammation by HMGB1 activation of TLR4 at the syncytium. Placenta. 53-61.
  • 2018. Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study. British Journal of Cancer. 1123-1129.
  • 2017. Variants in the fetal genome near FLT1 are associated with risk of preeclampsia. Nature Genetics. 1255-1260.
  • 2016. The antihypertensive MTHFR gene polymorphism rs17367504-G is a possible novel protective locus for preeclampsia. Journal of Hypertension. 132-139.
  • 2016. Adult body-mass index and ovarian cancer risk by subtype: A Mendelian randomization study. International Journal of Epidemiology. 884-895.
  • 2015. The Norwegian preeclampsia family cohort study: a new resource for investigating genetic aspects and heritability of preeclampsia and related phenotypes. BMC Pregnancy and Childbirth. 1-12.
  • 2015. Refined phenotyping identifies links between preeclampsia and related diseases in a Norwegian preeclampsia family cohort. Journal of Hypertension. 2294-2302.
  • 2015. Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics. Placenta. 1455-1462.
  • 2013. Validity of the diagnosis of pre-eclampsia in the Medical Birth Registry of Norway. Acta Obstetricia et Gynecologica Scandinavica. 943-950.
  • 2013. Validity of pre-eclampsia diagnosis in Medical Birth Registry of Norway. Acta Obstetricia et Gynecologica Scandinavica. 243-950.
Faglig foredrag
  • 2019. The NLRP3 inflammasome expression by maternal and fetal cells in the uterine wall and association with preeclampsia development. .
  • 2019. NLRP3 inflammasome expression by maternal and fetal cells in decidua and its association with preeclampsia .
  • 2019. Divergent regulation of decidual oxidative stress response in preeclampsia with and without fetal growth restriction.
  • 2017. Inflammation in preeclampsia by NOD-like receptor protein (NLRP)3 inflammasome activation in trophoblasts.
  • 2017. An inflammatory role for NOD1 in decidua and placenta of normal and preeclamptic pregnancies.
  • 2014. Inflammation in normal and preeclamptic pregnancies.
Vitenskapelig foredrag
  • 2018. Decidual inflammation in normal and preeclamptic pregnancies.
  • 2016. Decidual Nrf2-mediated oxidative stress response in preeclampsia and fetal growth restriction.
  • 2015. The inflammatory role of HMGB1 in preeclampsia.
  • 2013. Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi.
  • 2013. A preeclampsia genome-wide linkage scan in Norwegian families.
Doktorgradsavhandling
  • 2015. Preeclampsia: Specific genetic risk factors and shared predisposition with cardiovascular disease.
Intervju
  • 2017. Fars gener bidrar til at mor får svangerskapsforgiftning.
Dokumentar
  • 2014. Svangerskapsforgiftning gir økt risiko for hjerte- og karsykdom.
Sammendrag/abstract
  • 2019. Toll-like receptor 3 expression and activation at the maternal-fetal interface in pregnancy . Clinical medicine (London).
  • 2019. Toll-Like Receptor-3 expression by maternal and fetal cells at the maternal-fetal interface is associated with development of preeclampsia. Pregnancy Hypertension. S15.
  • 2019. The NLRP3 inflammasome expression by maternal and fetal cells in the uterine wall and association with preeclampsia development. Placenta. e15.
  • 2019. Metabolomics identifies placental dysfunction and confirms Flt-1 biomarker specificity. Pregnancy Hypertension. S5.
  • 2019. Divergent regulation of decidual oxidative stress response in preeclampsia with and without fetal growth restriction. Pregnancy Hypertension. S21.
  • 2018. Decidual inflammation in normal and preeclamptic pregnancies. Pregnancy Hypertension. S33-S34.
  • 2017. Inflammation in preeclampsia by NOD-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. Pregnancy Hypertension. 21.
  • 2017. An inflammatory role for TLR3 in decidua and placenta of normal and preeclamptic pregnancies. Placenta. 278.
  • 2017. An inflammatory role for NOD1 in decidua and placenta of normal and preeclamptic pregnancies. Placenta. 235.
  • 2016. NLRP3 inflammasome expression and activation at the maternal-fetal interface in preeclamptic and healthy pregnancies. Placenta. 88-88.
  • 2015. The inflammatory role of HMGB1 in preeclampsia. Pregnancy Hypertension. 229.
  • 2015. Identifying a novel link between preeclampsia and chronic hypertension in the MTHFR gene using the population based Norwegian HUNT Study. Pregnancy Hypertension. 243-244.
  • 2015. A genetic connection between preeclampsia and chronic hypertension in Norwegian families. Pregnancy Hypertension. 138-139.
  • 2013. Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi. Gynekologen. 43-44.
  • 2013. A preeclampsia genome-wide linkage scan in Norwegian families. Pregnancy Hypertension. 64.
  • 2012. INVESTIGATING GENETIC PREDISPOSITION AND CLINICAL OCCURRENCE OF PREECLAMPSIA AND CARDIOVASCULAR DISEASE THROUGH A FAMILY-BASED DESIGN. Placenta. A82-A82.
  • 2012. A population and family based study design to investigate genetic predisposition to preeclampsia and cardiovascular disease. The Norwegian Preeclampsia Family Study. Acta Obstetricia et Gynecologica Scandinavica. 135-136.
  • 2011. Establishment of a Norwegian Preeclampsia Family Biobank. Placenta. A85-A85.
Poster
  • 2019. Toll-Like Receptor-3 expression by maternal and fetal cells at the maternal-fetal interface is associated with development of preeclampsia .
  • 2019. Toll-Like Receptor-3 expression by maternal and fetal cells at the maternal-fetal interface is associated with development of preeclampsia.
  • 2019. Metabolomics identifies placental dysfunction and confirms Flt-1 biomarker specificity.
  • 2018. TLR3 expression and activation at the maternal-fetal interface in pregnancy.
  • 2018. Inflammation at the uterine wall lining in pregnancy.
  • 2017. An inflammatory role for TLR3 in decidua and placenta of normal and preeclamptic pregnancies.
  • 2016. Toll-like receptor 3 expression and activation at the maternal-fetal interface in pregnancy.
  • 2016. Nrf2-mediated oxidative stress response at the maternal-fetal interface in preeclampsia and fetal growth restriction.
  • 2016. NLRP3 inflammasome expression and activation at the maternal-fetal interface in preeclamptic and healthy pregnancies.
  • 2016. First genome-wide significant locus for pre-eclampsia susceptibility discovered on fetal chromosome 13 near FLT1.
  • 2015. The inflammatory role of HMGB1 in preeclamptic and normal pregnancies.
  • 2015. The NLRP3 inflammasome in placentas from preeclamptic and healthy pregnancies.
  • 2015. Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics.
  • 2014. Heritability of cardiovascular diseases in a preeclampsia family cohort.
  • 2014. A genetic connection between preeclampsia and chronic hypertension in Norwegian families.
  • 2013. Heritability of cardiovascular diseases in a preeclampsia family cohort.
  • 2012. A family based cohort study design to investigate genetic predisposition to preeclampsia and cardiovascular disease. The Norwegian Preeclampsia Family Study.
Vitenskapelig oversiktsartikkel/review
  • 2020. TLR3 expression by maternal and fetal cells at the maternal-fetal interface in normal and preeclamptic pregnancies. 1-11.
Fagartikkel
  • 2016. Chapter 28 Hypertensive disorders of pregnancy and eclampsia. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 171-178.
Faglig kapittel
  • 2014. Hypertensive svangerskapskomplikasjoner og eklampsi. . I:
    • 2014. Veileder i fødselshjelp 2014. .

Se fullstendig oversikt over publikasjoner i CRIStin.